What currency is ARKM?

ARKM, an exchange-traded fund (ETF) ticker, represents the ARK Genomic Revolution Multi-Sector ETF, which invests in companies leveraging genomics for healthcare advancements.

Nov 20, 2024 at 02:06 am

What Currency is ARKM?

ARKM is a ticker symbol for an actively managed exchange-traded fund (ETF) called ARK Genomic Revolution Multi-Sector ETF. It is not a currency. ARKM invests in companies that are focused on genomic sequencing and analysis, as well as other areas of biotechnology.

Understanding ARKM ETF

1. Investment Objective:

ARKM's primary objective is to provide capital appreciation by investing in companies involved in the genomic revolution. This includes companies engaged in genetic sequencing, gene editing, personalized medicine, gene therapy, and other related technologies.

2. Investment Strategy:

ARKM follows an active management approach, where the fund manager actively selects stocks based on their research and analysis. The fund primarily invests in US-listed companies but may also allocate up to 20% of its assets to non-US companies.

3. Risk Profile:

ARKM is considered a high-risk investment due to its focus on the emerging and rapidly evolving field of genomics. The fund's value can fluctuate significantly based on the performance of its underlying holdings and the overall market conditions.

4. Top Holdings:

As of January 2023, ARKM's top holdings include:

• Regeneron Pharmaceuticals (REGN)
• Editas Medicine (EDIT)
• Intellia Therapeutics (NTLA)
• CRISPR Therapeutics (CRSP)
• Vertex Pharmaceuticals (VRTX)

5. Performance:

ARKM has experienced strong growth since its inception in 2014. However, it has also been subject to significant volatility due to its high-risk profile. investors should carefully consider their risk tolerance and investment horizon before investing in ARKM.

6. Expenses:

ARKM has an expense ratio of 0.75%, which is higher than most other ETFs. This expense ratio covers the fund's management and operating costs, such as research expenses and marketing costs.

7. Suitability:

ARKM is suitable for investors who:

• Understand the high-risk nature of investing in the genomics industry
• Have a long-term investment horizon
• Are tolerant of significant volatility in their portfolio
• Are comfortable with actively managed investments

8. Alternatives to ARKM:

Investors seeking exposure to the genomics industry may consider the following alternative ETFs:

• ARK Genomic Revolution ETF (ARKG): A more focused ETF that invests solely in companies engaged in genomics research and development.
• SPDR S&P Biotech ETF (XBI): A broader ETF that invests in a range of biotechnology companies, including some with a focus on genomics.
• iShares Nasdaq Biotechnology Index ETF (IBB): A similar ETF to XBI that provides exposure to leading biotechnology companies, including those involved in genomics.